JKTBP (HNRNPDL) is a novel toll7/9 dependent target in humans and animal models 
of inflammatory rheumatic diseases.

Marklein, B.; Konthur, Z.; Cope, A.; Shlomchik, M.; Burmester, G.; Skriner, K.

doi:10.110.1136/ard.2010.129577h

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

JKTBP (HNRNPDL) is a novel toll7/9 dependent target in humans and animal models of inflammatory rheumatic diseases.

MPS-Authors

/persons/resource/persons50390

Konthur, Z.
In vitro Ligand Screening (Zoltán Konthur), Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Ann Rheum Dis-2010-Marklein-A4.pdf
(Any fulltext), 64KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Marklein, B., Konthur, Z., Cope, A., Shlomchik, M., Burmester, G., & Skriner, K. (2011). JKTBP (HNRNPDL) is a novel toll7/9 dependent target in humans and animal models of inflammatory rheumatic diseases. Annals of the Rheumatic Diseases, 69(Suppl 2). doi:10.110.1136/ard.2010.129577h.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-77B9-9

Abstract

There is no abstract available